Skip to main content
. 2015 Jul 17;2(11):1500053. doi: 10.1002/advs.201500053

Figure 2.

Figure 2

Pathways, targets and emerging targeted agents in TNBC. VEGFR: vascular endothelial growth factor receptor; EGFR: epidermal growth factor receptor; HSP90: heat‐shock protein 90; TK: tyrosine kinase; PI3K: phosphoinositide‐3‐kinase; PARP1: poly(ADP‐ribose)polymerase 1; PDK: 30‐phosphoinositide‐dependent kinase; MAPK: Mitogen‐activated protein kinase; mTOR: mammalian target of rapamycin.